InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) traded down 7.1% on Thursday. The company traded as low as $8.42 and last traded at $8.2750. Approximately 71,693 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 385,207 shares. The stock had previously closed at $8.91.
Wall Street Analysts Forecast Growth
Several brokerages have commented on INNV. Zacks Research upgraded shares of InnovAge from a "hold" rating to a "strong-buy" rating in a report on Monday. Weiss Ratings upgraded shares of InnovAge from a "sell (d-)" rating to a "hold (c-)" rating in a research note on Wednesday, November 4th. Wall Street Zen raised shares of InnovAge from a "buy" rating to a "strong-buy" rating in a report on Saturday, November 7th. Finally, KeyCorp increased their price objective on shares of InnovAge from $13.00 to $14.00 and gave the stock an "overweight" rating in a research note on Wednesday, September 9th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, InnovAge presently has a consensus rating of "Moderate Buy" and an average price target of $10.50.
View Our Latest Analysis on INNV
InnovAge Stock Performance
The firm's fifty day moving average price is $9.42 and its 200 day moving average price is $9.27. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a market cap of $1.18 billion, a P/E ratio of 144.63 and a beta of 0.16.
InnovAge (NASDAQ:INNV - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. InnovAge had a net margin of 0.88% and a return on equity of 3.63%. The firm had revenue of $264.76 million during the quarter, compared to analyst estimates of $257.23 million. Sell-side analysts expect that InnovAge Holding Corp. will post 0.44 EPS for the current fiscal year.
Insider Buying and Selling at InnovAge
In related news, major shareholder Aggregator Lp Ignite sold 1,500,000 shares of the firm's stock in a transaction on Wednesday, October 21st. The shares were sold at an average price of $9.25, for a total transaction of $13,875,000.00. Following the completion of the transaction, the insider owned 101,076,555 shares of the company's stock, valued at $934,958,133.75. This trade represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Nicole Damato sold 3,402 shares of the business's stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $9.51, for a total value of $32,353.02. Following the completion of the transaction, the insider directly owned 301,495 shares of the company's stock, valued at approximately $2,867,217.45. This trade represents a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 13,027,216 shares of company stock worth $120,489,535. Company insiders own 1.10% of the company's stock.
Institutional Trading of InnovAge
Institutional investors have recently made changes to their positions in the company. Aquatic Capital Management LLC purchased a new position in InnovAge during the third quarter worth about $100,000. Goldman Sachs Group Inc. boosted its position in shares of InnovAge by 207.1% during the third quarter. Goldman Sachs Group Inc. now owns 668,219 shares of the company's stock worth $5,880,000 after buying an additional 450,610 shares during the period. Jump Financial LLC acquired a new position in InnovAge in the 3rd quarter valued at about $1,096,000. Marshall Wace LLP purchased a new stake in InnovAge during the 3rd quarter worth approximately $3,589,000. Finally, Empowered Funds LLC acquired a new stake in shares of InnovAge in the third quarter valued at $407,000. 12.26% of the stock is owned by institutional investors and hedge funds.
InnovAge Company Profile
(
Get Free Report)
InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge's services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.